Survival outcomes in atypical teratoid rhabdoid tumor for patients undergoing radiotherapy in a Surveillance, Epidemiology, and End Results analysis

被引:128
|
作者
Buscariollo, Daniela L. [1 ]
Park, Henry S. [2 ]
Roberts, Kenneth B. [2 ,3 ]
Yu, James B. [2 ,3 ]
机构
[1] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA
[2] Yale Univ, Sch Med, New Haven, CT USA
[3] Yale Univ, Canc Outcomes Publ Policy & Effectiveness Res COP, New Haven, CT USA
关键词
atypical teratoid rhabdoid tumor; central nervous system; epidemiology; radiotherapy; children; CENTRAL-NERVOUS-SYSTEM; TERATOID/RHABDOID TUMOR; RADIATION-THERAPY; CHILDREN; CHILDHOOD; CHEMOTHERAPY; INFANCY; ATRT;
D O I
10.1002/cncr.27373
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Atypical teratoid rhabdoid tumor (ATRT) is a rare central nervous system malignancy with a poor prognosis that affects mostly young children. Although radiotherapy (RT) historically has been delayed in patients aged <3 years, emerging evidence suggests a role for RT to achieve long-term survivorship. Clinical features and age-dependent trends of RT use were evaluated for patients with ATRT. METHODS: The National Cancer Institute's Surveillance, Epidemiology, and End Results database was used to identify 144 patients with ATRT from 1973 to 2008. The primary endpoint was median overall survival (OS). Clinical and treatment variables were assessed for an association with OS using Cox proportional hazards models. Landmark analysis was used to correct for immortal time bias of adjuvant RT. RESULTS: The median age at diagnosis was 1 year (range, 0-67 years). Gross total resection of the primary tumor was achieved in 39% of patients, and 33% of patients received RT. From 1992 to 2008, RT use increased 2.4-fold in patients aged =3 years. The median OS for was 10 months. In multivariate analyses, metastatic disease (hazard ratio, 2.83; 95% confidence interval, 1.53-5.23; P = .001) and RT (hazard ratio, 0.10; 95% confidence interval, 0.01-0.73; P = .02) were identified as independent predictors of survival. Landmark analysis confirmed a robust association between RT use and survival, which was attenuated in patients ages 4 to 17 years compared with younger patients. CONCLUSIONS: The current results indicated that RT may offer a significant survival benefit for patients with ATRT and that patients aged =3 years may derive more benefit from initial RT compared with older children. The authors concluded that prospective clinical trials are needed to examine the role of RT in the initial management of ATRT in patients aged <3 years. Cancer 2012. (c) 2011 American Cancer Society.
引用
收藏
页码:4212 / 4219
页数:8
相关论文
共 50 条
  • [1] Trimodality therapy for atypical teratoid/rhabdoid tumor is associated with improved overall survival: A surveillance, epidemiology, and end results analysis
    Quinn, Thomas J.
    Alrnahariq, Muayad F.
    Siddiqui, Zaid A.
    Thompson, Andrew B.
    Hannstra, Daniel A.
    Kabolizadeh, Peyman
    Gowans, Kate L.
    Chen, Peter Y.
    PEDIATRIC BLOOD & CANCER, 2019, 66 (12)
  • [2] Survival Benefit from Multimodal Treatment for Patients with Atypical Teratoid Rhabdoid Tumor in a Surveillance, Epidemiology and End Result Database Analysis
    Bhutada, Abhishek S.
    Adhikari, Srijan
    Cuoco, Joshua A.
    Rogers, Cara M.
    Marvin, Eric A.
    ONCOLOGY, 2024, 102 (02) : 183 - 194
  • [3] Radiotherapy in pediatric patients with atypical teratoid rhabdoid tumor of the central nervous system
    Frick, Melissa
    Minturn, Jane
    Li, Yi-Mei
    Hill-Kayser, Christine
    CANCER RESEARCH, 2016, 76
  • [4] Atypical Teratoid Rhabdoid Tumor (ATRT): Hacettepe Results
    Akyuz, C.
    Aydin, B.
    Kalkan, N.
    Yalcin, B.
    Kurucu, N.
    Varan, A.
    Kutluk, T.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S426 - S426
  • [5] COMPARATIVE MOLECULAR ANALYSIS OF ATYPICAL TERATOID/RHABDOID TUMOR TO KIDNEY RHABDOID TUMOR
    Birks, Diane
    Donson, Andrew
    Dunham, Christopher
    Muscat, Andrea
    Algar, Elizabeth
    Ashley, David
    Handler, Michael
    Foreman, Nicholas
    NEURO-ONCOLOGY, 2011, 13 : I11 - I11
  • [6] Atypical teratoid/rhabdoid tumor in adult: case series and an integrated survival analysis
    Peng, Ai Jun
    Fan, Shu Cai
    Chen, Ya Xing
    Huang, Jian Han
    Cao, Yi
    Zhou, Liang Xue
    Chen, Ni
    BRITISH JOURNAL OF NEUROSURGERY, 2024, 38 (02) : 425 - 432
  • [7] A case of atypical teratoid/rhabdoid tumor in an adult, with long survival
    Kenta Takahashi
    Hiroshi Nishihara
    Masahito Katoh
    Tomoaki Yoshinaga
    Roshan Mahabir
    Hiromi Kanno
    Taichi Kimura
    Mishie Tanino
    Jun Ikeda
    Yutaka Sawamura
    Kazuo Nagashima
    Shinya Tanaka
    Brain Tumor Pathology, 2011, 28 : 71 - 76
  • [8] A case of atypical teratoid/rhabdoid tumor in an adult, with long survival
    Takahashi, Kenta
    Nishihara, Hiroshi
    Katoh, Masahito
    Yoshinaga, Tomoaki
    Mahabir, Roshan
    Kanno, Hiromi
    Kimura, Taichi
    Tanino, Mishie
    Ikeda, Jun
    Sawamura, Yutaka
    Nagashima, Kazuo
    Tanaka, Shinya
    BRAIN TUMOR PATHOLOGY, 2011, 28 (01) : 71 - 76
  • [9] Atypical teratoid rhabdoid tumors: a population-based clinical outcomes study involving 174 patients from the Surveillance, Epidemiology, and End Results database (1973-2010)
    Lau, Christine S. M.
    Mahendraraj, Krishnaraj
    Chamberlain, Ronald S.
    CANCER MANAGEMENT AND RESEARCH, 2015, 7 : 301 - 309
  • [10] Impact of Radiotherapy on Overall Survival in Children with Atypical Teratoid Rhabdoid Tumors
    Panandiker, A. S. Pai
    Beltran, C.
    Naik, M.
    Sharma, S.
    Gajjar, A.
    Merchant, T. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S38 - S39